RecruitingHeart Failure

HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry

Eligible age

18–100 yrs

Accepts

All genders

Locations

10 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of the HF2 (Hemodynamic Frontiers in Heart Failure) registry is to collect relevant patient-level demographic, clinical, laboratory, and hemodynamic data from patients implanted with pulmonary artery pressure sensor at participating centers to advance scientific knowledge about ambulatory hemodynamics monitoring and HF (Heart Failure) therapies. The data collected will be used for retrospective studies, quality improvement, identifying research cohorts, and member-initiated research.

Sponsor: University of Kansas Medical Center

You may qualify if…

✓ 1. All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization.
✓ 2. Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II).

You may not qualify if…

✕ 1. Patients less than 18 years of age.
✕ 2. Pregnant women at the scheduled time of PA pressure sensor implant.
✕ 3. Patients unable or unwilling to have continuity of care in the heart failure clinic.